African swine fever virus (ASFV) is a highly virulent DNA virus that has spread globally since its introduction into Georgia in 2007, causing substantial economic losses in the swine industry. In the absence of an effective vaccine, chemical disinfection remains a key strategy for disease control. However, in cell-based disinfectant efficacy testing, distinguishing between disinfectant-induced cytotoxicity and virus-induced cytopathic effects (CPEs) remains a major challenge, leading to the potential misinterpretation of results. To address this, we developed a multi-step analytical framework to differentiate CPEs from cytotoxicity using a Vero cell-adapted ASFV strain. Virkon® S was tested at three dilutions—375×, 275× (manufacturer-recommended), and 175×—and evaluated through CPE observation, lactate dehydrogenase (LDH) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, and antigen detection via lateral flow immunoassay (p30) and immunofluorescence (p54). Notably, the 375× dilution achieved effective viral inactivation with significantly lower cytotoxicity, demonstrating that this framework can facilitate a more refined determination of disinfectant working dilutions. Furthermore, increased p30 signals after disinfection and the observation of lower cytotoxicity in virus-plus-disinfectant groups compared to disinfectant-only groups highlight the complexity of virus-disinfectant interactions and the potential for misinterpretation. This study provides a standardized and interpretable strategy for assessing ASFV disinfectant efficacy and offers a practical basis for evaluating other enveloped viruses in future disinfection studies.
Transboundary animal diseases (TADs) pose persistent threats to global livestock production, and chemical disinfection remains a critical component of biosecurity. However, virucidal efficacy is commonly assessed using single-condition endpoints, limiting comparative interpretation across biologically heterogeneous viruses. In this study, an experimental framework explicitly structured across virus species, disinfectant concentration, and contact time was applied to systematically compare virucidal response patterns across four major TAD viruses—avian influenza virus, African swine fever virus, foot-and-mouth disease virus, and lumpy skin disease virus. Four representative disinfectant active ingredients from distinct chemical classes were evaluated across multiple concentrations and defined contact times using quantitative suspension assays. Virucidal efficacy was quantified using log10 reduction values, and critical concentrations required to achieve ≥4 log10 reduction were derived for comparative analysis. Distinct concentration–response profiles were observed among disinfectant classes, with some ingredients showing relatively consistent activity across viruses, while others exhibited pronounced virus-specific thresholds. Notably, enveloped viruses did not uniformly display higher susceptibility, and extension of contact time enhanced efficacy predominantly in an ingredient-dependent manner. To integrate these multifactorial outcomes at the virus level, a quartile-based analysis was applied, providing a conservative indicator of relative viral resistance across disinfectants and exposure conditions. Overall, these findings demonstrate that virucidal susceptibility is shaped by interactions between disinfectant chemistry and exposure parameters, and support concentration–time-resolved, pattern-based evaluation frameworks—supplemented by quartile-based resistance ranking—beyond single-condition endpoints for assessing disinfectant efficacy against animal viruses.
Chemical disinfectants used in livestock production commonly combine citric acid (CA) and benzalkonium chloride (BZK), yet the respective contributions of these active ingredients to virucidal efficacy remain poorly understood. This study quantified the relative contributions of CA and BZK against the non-enveloped foot-and-mouth disease virus (FMDV) and the enveloped avian influenza virus (AIV). Virucidal efficacy was evaluated using a full-factorial design comprising six CA concentrations and six BZK concentrations at contact times of 3 and 30 min. Log reduction values (LRVs) were analyzed by two-way ANOVA and multiple linear regression, and the relative importance of each predictor was estimated using the Lindeman–Merenda–Gold (LMG) method. FMDV inactivation was primarily determined by CA, which accounted for 99.99% and 99.87% of the explained variance at 3 and 30 min, respectively, whereas BZK and the interaction term contributed minimally. In contrast, BZK was the dominant determinant of AIV inactivation, explaining 69.79% and 78.02% of the variance at 3 and 30 min, respectively, while CA made a smaller contribution. These findings demonstrate that the dominant active ingredient in CA–BZK combination disinfectants differed markedly between the FMDV and AIV models examined. Quantifying the relative contribution of individual components provides a basis for the rational formulation and optimization of veterinary disinfectants for different target viruses.
Surrogate viruses provide a safe and scalable alternative for evaluating disinfectant efficacy when access to high-risk pathogens is restricted. This study evaluated the potential of Modified Vaccinia Ankara (MVA) virus, which can be handled under BSL-1/2 conditions, as a surrogate for avian influenza virus (AIV), foot-and-mouth disease virus (FMDV), and African swine fever virus (ASFV). A total of 64 commercially available disinfectants—classified into four major chemical groups: quaternary ammonium compounds, oxidizing agents, PPMS-based formulations, and organic acids—were tested in suspension assays using a ≥4 log reduction as the efficacy criterion. MVA showed the strongest predictive performance for FMDV (r = 0.671, AUC = 0.83), supporting its use for both binary classification and approximate quantitative prediction. Although its correlation with ASFV was weaker (r = 0.175), the classification performance remained moderate (AUC = 0.78), indicating conditional applicability. While MVA exhibited no meaningful correlation with AIV, its higher chemical resistance meant that disinfectants effective against MVA were consistently effective against AIV. These results support the use of MVA as a conservative exclusion tool for fragile viruses. Overall, the findings demonstrate that MVA can serve as a practical surrogate virus for disinfectant efficacy testing against FMDV, ASFV, and AIV, with application strategies tailored to each virus’s characteristics.
Long-term stability of veterinary disinfectants depends not only on the preservation of active-ingredient content but also on the maintenance of biological efficacy. This study evaluated the 24-month real-time chemical and virucidal stability of five powder formulations (powder F1–F5) containing potassium peroxymonosulfate (PPMS) and malic acid (MA) and five liquid formulations (liquid F1–F5) containing benzalkonium chloride (BZK) and citric acid (CA). At six storage time points (months 0, 3, 6, 12, 18, and 24), active-ingredient contents were quantified and virucidal efficacy against modified vaccinia virus Ankara (MVA) was assessed at 25-, 100-, and 300-fold dilutions. Associations between remaining active-ingredient content and virucidal efficacy were analyzed using repeated-measures correlation. In the powder formulations, PPMS and MA contents progressively decreased during storage, accompanied by corresponding reductions in virucidal efficacy, with strong positive correlations between remaining content and efficacy. In contrast, BZK and CA contents in the liquid formulations remained relatively stable, whereas virucidal efficacy declined substantially in several formulations, showing weaker content–efficacy associations. The F1 formulations, representing composition ratios commonly used in commercial disinfectants, showed different stability patterns: powder F1 exhibited comparatively favorable efficacy retention, whereas liquid F1 maintained efficacy near its initial level through month 18 but declined markedly by month 24. These findings demonstrate that chemical and functional stability may diverge during prolonged storage and support consideration of biological efficacy testing as a complementary measure to active-ingredient analysis under the conditions investigated.